Page last updated: 2024-08-18

phenylpiperazine and Arrhythmias, Cardiac

phenylpiperazine has been researched along with Arrhythmias, Cardiac in 1 studies

*Arrhythmias, Cardiac: Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Argentieri, T; Gomez, RP; Lind, JM; Lis, R; Lumma, WC; Morgan, TK; Phillips, GB; Sullivan, ME1

Other Studies

1 other study(ies) available for phenylpiperazine and Arrhythmias, Cardiac

ArticleYear
Synthesis, cardiac electrophysiology, and beta-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents.
    Journal of medicinal chemistry, 1992, Feb-21, Volume: 35, Issue:4

    Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzamides; Binding, Competitive; Dogs; Electric Stimulation; Electrophysiology; Epinephrine; Heart; Molecular Structure; Piperazines; Purkinje Fibers; Receptors, Adrenergic, beta; Sotalol; Structure-Activity Relationship

1992